JBIO

Jade Biosciences, Inc. Common Stock
JBIO

Overview Fund Activity

47 hedge funds and large institutions have $302M invested in Jade Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.73%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
12
Increased
16
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$8.61M
2
BBA
2
Baker Bros. Advisors
New York
$21.6M
3
FAM
3
Fred Alger Management
New York
$1.97M
4
Norges Bank
4
Norges Bank
Norway
$1.2M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.86M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.52M
3
CAM
3
Cormorant Asset Management
Massachusetts
$21.6M
4
Millennium Management
4
Millennium Management
New York
$0
5
PPA
5
Parametric Portfolio Associates
Washington
$424K
Name Market Value Shares Shares
Change 		Shares
Change %
DGM
51
Darwin Global Management
Jersey
– – -12,484 Closed
CSS
52
Cubist Systematic Strategies
Connecticut
– – -775 Closed
PHK
53
Point72 Hong Kong
Hong Kong
– – -285 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3